Hims Hers Health is trading at $26.14 (up 4.6%) as investors buy the recent dip following a sharp multi-day pullback earlier this week.
- The move appears driven by dip-buying and improving broader market sentiment as major U.S. indices rebound strongly, despite no fresh company-specific news or filings today.
- The recovery follows significant profit-taking that saw the stock decline nearly 15% on July 29 after its strong rally throughout the month.